The medication is administered once weekly via subcutaneous injection, with doses typically initiated at 2.5 mg (an initiation dose not intended for glycemic control) and gradually titrated upward (5 mg, 7.5 mg, 10 mg, 12.5 mg, to a maximum of 15 mg) based on glycemic response, weight loss goals, and tolerability
Your provider should guide this decision
As a brand-name medication, Rybelsus isnt cheap
GLP-1 receptor agonist 8 GLP-1 receptor agonist 8 is a potent agonist of GLP-1 R
PubMed laboratory research record [PMID: 42035774] PubMed record related to this compound for laboratory literature review
Supports Hair & Scalp Health: May strengthen follicles, promote healthier hair growth, and improve scalp vitality